fludrocortisone has been researched along with prorenoate potassium in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ramsay, LE; Shelton, JR; Tidd, MJ | 1 |
Harrison, I; Ramsay, L; Shelton, J; Tidd, M | 1 |
McInnes, GT; Ramsay, LE; Shelton, JR | 1 |
Harrison, IR; McInnes, GT; Palmer, RF; Perkins, RM; Shelton, JR | 1 |
Harrison, IR; McInnes, GT; Shelton, JR | 1 |
1 review(s) available for fludrocortisone and prorenoate potassium
Article | Year |
---|---|
Evaluation of aldosterone antagonists in healthy man.
Topics: Aldosterone; Animals; Diuretics; Dogs; Drug Evaluation; Drug Evaluation, Preclinical; Fludrocortisone; Humans; In Vitro Techniques; Male; Mineralocorticoid Receptor Antagonists; Potassium; Rats; Sodium; Spironolactone | 1982 |
3 trial(s) available for fludrocortisone and prorenoate potassium
Article | Year |
---|---|
The pharmacodynamics of single doses of prorenoate potasssium and spironolactone in fludrocortisone treated normal subjects.
Topics: Administration, Oral; Adolescent; Adult; Canrenoic Acid; Clinical Trials as Topic; Diuresis; Fludrocortisone; Humans; Male; Potassium; Pregnadienes; Sodium; Spironolactone; Time Factors | 1976 |
Relative potency of prorenoate and spironolactone in normal man.
Topics: Adolescent; Adult; Canrenoic Acid; Clinical Trials as Topic; Creatinine; Dose-Response Relationship, Drug; Fludrocortisone; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Potassium; Pregnadienes; Sodium; Spironolactone | 1975 |
Comparison of prorenoate potassium and spironolactone after repeated doses and steady state plasma levels of active metabolites.
Topics: Adolescent; Adult; Electrolytes; Fludrocortisone; Humans; Male; Mineralocorticoids; Potassium; Spironolactone | 1982 |
1 other study(ies) available for fludrocortisone and prorenoate potassium
Article | Year |
---|---|
Steady-state relative potency of aldosterone antagonists: spironolactone and prorenoate.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Fludrocortisone; Humans; Male; Mineralocorticoid Receptor Antagonists; Potassium; Sodium; Spironolactone | 1981 |